13F
中

VMD VIEMED HEALTHCARE INC

2026Q1 · CUSIP 92663R105 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
147
Δ holders QoQ
+17
Breadth percentile
Top 18%
Whale holders
72
Δ whales
+3
Inst. holding value
$228M
New positions
32
Closed positions
15
Price momentum (1Q)
+15.3%
Put / Call
0/0

Breadth history (34 quarters)

2018Q2: Δ+0 · h=1 2018Q3: Δ+0 · h=1 2019Q3: Δ+33 · h=34 2019Q4: Δ+7 · h=41 2020Q1: Δ+0 · h=41 2020Q2: Δ+52 · h=93 2020Q3: Δ+4 · h=97 2020Q4: Δ+3 · h=100 2021Q1: Δ-1 · h=99 2021Q2: Δ-23 · h=76 2021Q3: Δ+5 · h=81 2021Q4: Δ+3 · h=84 2022Q1: Δ+2 · h=86 2022Q2: Δ-11 · h=75 2022Q3: Δ-11 · h=64 2022Q4: Δ+16 · h=80 2023Q1: Δ+8 · h=88 2023Q2: Δ+16 · h=104 2023Q3: Δ+9 · h=113 2023Q4: Δ-9 · h=104 2024Q1: Δ+8 · h=112 2024Q2: Δ+5 · h=117 2024Q3: Δ+5 · h=122 2024Q4: Δ+21 · h=143 2025Q1: Δ-3 · h=140 2025Q2: Δ-14 · h=126 2025Q3: Δ+5 · h=131 2025Q4: Δ-1 · h=130 2026Q1: Δ+17 · h=147 2018Q2: holders=1 2018Q3: holders=1 2019Q3: holders=34 2019Q4: holders=41 2020Q1: holders=41 2020Q2: holders=93 2020Q3: holders=97 2020Q4: holders=100 2021Q1: holders=99 2021Q2: holders=76 2021Q3: holders=81 2021Q4: holders=84 2022Q1: holders=86 2022Q2: holders=75 2022Q3: holders=64 2022Q4: holders=80 2023Q1: holders=88 2023Q2: holders=104 2023Q3: holders=113 2023Q4: holders=104 2024Q1: holders=112 2024Q2: holders=117 2024Q3: holders=122 2024Q4: holders=143 2025Q1: holders=140 2025Q2: holders=126 2025Q3: holders=131 2025Q4: holders=130 2026Q1: holders=147 -52 -26 +0 +26 +52 078155 18Q219Q420Q321Q222Q122Q423Q324Q225Q125Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 5 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 18% — —
2023Q2 Top 14% -8.0% +10.6%
2023Q1 Top 19% -25.5% -30.8%
2020Q2 Top 5% -22.7% -7.3%
2019Q3 Top 3% — —

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
32.6
EPS (TTM)
$0.37
EPS YoY
+23.3%
Revenue (TTM)
$0.3B
Revenue YoY
+23.1%
Quarterly Revenue & EPS (4Y)
2022-06-30: $33M 2022-09-30: $36M 2022-12-31: $38M 2023-03-31: $40M 2023-06-30: $43M 2023-09-30: $49M 2023-12-31: $51M 2024-03-31: $51M 2024-06-30: $55M 2024-09-30: $58M 2024-12-31: $61M 2025-03-31: $59M 2025-06-30: $63M 2025-09-30: $72M 2025-12-31: $76M 2026-03-31: $75M 2022-06-30: EPS 0.02 2022-09-30: EPS 0.03 2022-12-31: EPS 0.07 2023-03-31: EPS 0.04 2023-06-30: EPS 0.06 2023-09-30: EPS 0.07 2023-12-31: EPS 0.08 2024-03-31: EPS 0.04 2024-06-30: EPS 0.04 2024-09-30: EPS 0.10 2024-12-31: EPS 0.10 2025-03-31: EPS 0.06 2025-06-30: EPS 0.08 2025-09-30: EPS 0.09 2025-12-31: EPS 0.14 2026-03-31: EPS 0.06 0M 38M 76M $M 0.00 0.08 0.15 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 28 2023-03-31: PE 65.42023-06-30: PE 40.12023-09-30: PE 30.82023-12-31: PE 34.62024-03-31: PE 28.42024-06-30: PE 32.32024-09-30: PE 342024-12-31: PE 282025-03-31: PE 22.52025-06-30: PE 20.32025-09-30: PE 19.42025-12-31: PE 22.42026-03-31: PE 25.3 17 43 69 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)